---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-048687"
form_type: "8-K"
ticker: "JUNS"
cik: "0001679628"
company_name: "JUPITER NEUROSCIENCES, INC."
filed_at: "2024-12-04T23:59:59+00:00"
generated_at: "2026-05-29T08:43:26.456953+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Jupiter Neurosciences closes IPO on Nasdaq, raises $11M gross from 2.75M shares at $4.00

## Summary
- IPO of 2,750,000 common shares priced at $4.00/sh for gross proceeds of $11M.
- Net proceeds to Jupiter are approximately $9.5M after underwriting discounts and expenses.
- Shares began trading on Nasdaq Capital Market on Dec 3, 2024 under ticker JUNS.
- Proceeds earmarked for Phase II trial of JOTROL in Parkinson's, SE Asia initiatives, R&D, license fees, debt repayment, and working capital.
- Dominari Securities acted as lead underwriter; Revere Securities as co-manager.

## SEC filing metadata
- accession: 0001493152-24-048687
- form_type: 8-K
- ticker: JUNS
- cik: 0001679628
- company_name: JUPITER NEUROSCIENCES, INC.
- filed_at: 2024-12-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1679628/000149315224048687/0001493152-24-048687-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1679628/000149315224048687/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-048687
- JSON: https://secwatch.observer/filing/0001493152-24-048687.json
- Plain text: https://secwatch.observer/filing/0001493152-24-048687.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.